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Aberrant expression of microRNAs has been shown to regulate the biological processes of lung can-
cer cells. However, the role of miR-638 in the development of NSCLC is still unclear. In this study, low
miR-638 and high SOX2 were shown to be associated with tumor size and metastasis of NSCLC
patients. Downregulated miR-638 could promote cell invasion and proliferation, while high miR-
638 expression reversed the effect. Furthermore, miR-638 could regulate SOX2 by directly binding
to its 30-UTR. Silencing of SOX2 by siRNA partially abolished the enhancement of cell invasion and
proliferation induced by downregulated miR-638. Aberrant miR-638 expression could modulate
the expression levels of markers of epithelial-to-mesenchymal transition. Our results indicate that
miR-638 may play a pivotal role in the development of NSCLC.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Lung cancer is an aggressive malignancy, causing the most can-
cer-related deaths in the world. According to pathological pattern,
non-small-cell lung cancer (NSCLC) is mainly divided into squa-
mous cell carcinoma (SCC) and adenocarcinoma (AC) [1]. The rate
of 5-year survival was very low (approximately 10–15%) [2].
Metastasis, which is characterized by the ability of cancer cells to
invade into adjacent area, extravagate into blood or lymphatic ves-
sels, and extravagate into a distant environment, is required for
prognosis of patients with aggressive NSCLC [3]. Therefore, explo-
ration of the mechanism of metastasis would help us understand
the progression and the therapy for NSCLC.
microRNAs (miRNAs) are an abundant class of small non-coding
RNAs that play an important role in post-transcriptional regulation
in different biological processes [4,5]. The mature miRNAs are sin-
gle-stranded RNAs including 22nt nucleotides. Daochuan Li et al.
reported that miR-638 was decreased in 50 pairs of NSCLC tissues
and it was involved in the benzo(a)pyrene (BaP)-induced carcino-genesis by targeting BRCA1[6]. However, the potential mechanism
of miR-638 and the progression of NSCLC were not mentioned.
SRY (sex determining region Y)-box 2 (SOX2) is one of the
important transcriptional factors that regulate the unique proper-
ties of stem cells self-renewal and pluripotency and play a critical
role in maintaining the stem cell-like phenotype in cancer cells
[7,8]. Several studies reported that SOX2 contributed to tumori-
genesis and tumor progression of diverse cancers, including lung
cancer [9], breast cancer [10], esophageal cancer [11].
Epithelial-to-mesenchymal transition (EMT) serves as a pivotal
role in the invasion of various cancer cells by the transformation of
polarized and adherent epithelial cells into motile and invasive
mesenchymal cells [12,13]. Many transcription factors involved
in EMT such as Snail and Twist upregulate the expression of mes-
enchymal markers such as vimentin, collagen, ﬁbronectin and
downregulate the expression of epithelial markers such as E-cad-
herin. A breakdown of tight junctions is involved in loss of epithe-
lial markers and acquisition of mesenchymal makers [14,15].
In our study, we aimed to explore the crucial role of miR-638 in
NSCLC and found that miR-638 was related to tumor size and
metastasis. Furthermore, we identiﬁed that miR-638 could regu-
late the invasion and proliferation of NSCLC by targeting SOX2.
Moreover, miR-638 also could induce epithelial-to-mesenchymal
transition.
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2.1. Clinical samples
Lung cancer samples and the corresponding adjacent tissues
were collected from the 107 patients that had undergone routine
surgery at The First Afﬁliated Hospital of Nanjing Medical Univer-
sity from March 2010 and June 2013. All tissues were stored at
80 C until RNA extraction. This study was approved by the Eth-
ical Committee of The First Afﬁliated Hospital of Nanjing Medical
University, and every patient had written informed consent.
2.2. Cell culture
Five lung cancer cell lines (A549, H1299, SPCA1, H1650 and
H358) and normal lung cell (BEAS2B) were purchased from the
Institute of Biochemistry and Cell Biology of the Chinese Academy
of Sciences (Shanghai, China) and were cultured in RPMI-1640
medium with 10% fetal bovine serum (Invitrogen, Carlsbad, CA)
and penicillin (100 U/ml). Cells were cultured at 37 C with 5% CO2.
2.3. Isolation of total RNA and quantitative RT-PCR
RNA was extracted from all the tumor tissues and correspond-
ing adjacent samples by using TRIzol (Invitrogen, USA) and both
miRNA and mRNA were reversely transcribed to cDNA. The expres-
sion levels of miRNAs were analyzed by the TaqMan stem-loop
qRT-PCR method with a mirVana miRNA Detection Kit and gene-
speciﬁc primers. U6 small nuclear RNA was used for normalization.
Relative expression levels of SOX2 mRNA were assessed by SYBR
Green quantitative real-time PCR (qRT-PCR) and normalized to
GAPDH. qRT-PCR was performed by using the ABI 7900 Fast
Real-Time PCR system (ABI, CA, USA).
2.4. Invasion assay
Transwell assays were performed with BioCoat Matrigel (BD
Biosciences, San Jose, CA) and invasion chambers (Millipore, Esch-
born, Germany) with an 8-lm pore size according to the manufac-
turer’s instructions. The cells were stained with crystal violet. A set
of images was acquired using NIS Elements image analysis soft-
ware (Nikon, Tokyo, Japan). The values for invasion were obtained
by counting three ﬁelds per membrane and represented the aver-
age of three independent experiments.
2.5. MTT assay
All the cells were seeded into 96-well plates at 2000 cells/well.
Then, 20 lL of 3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di-phenytet-
razoliumromide (MTT) (0.5 mg/mL) was added into each well.
DMSO (200 lL) was added to each well to dissolve the precipitate.
Optical density was measured at the wavelength of 490 nm. The
data are derived from triplicate samples of at least 3 independent
experiments.
2.6. Apoptosis assay
Twenty-four hours after transfection, apoptosis in cultured cells
was evaluated using annexin V labeling. An annexin V-APC labeled
Apoptosis Detection Kit (Abcam) was used according to the manu-
facturer’s protocol.
2.7. Western blot
Cells were washed in PBS and lysed in RIPA lysis buffer
supplemented with protease inhibitor cocktail (Roche, Mannheim,Germany). Total protein was quantiﬁed using a BCA Protein Assay
Kit (Beyotime, Nanjing, China), and an equal amount of whole cell
lysates was resolved by SDS–polyacrylamide gel electrophoresis
(PAGE) and transferred to a polyvinylidene diﬂuoride (PVDF) mem-
brane (Millipore, Eschborn, Germany). The blots were blocked in
BSA (5% w/v in PBS + 0.1% Tween 20) for 1 h at room temperature
and immunostained with antibodies at 4 C overnight using anti-
SOX2 (1:500, santa, USA), anti-Fibronectin, anti-E-cadherin, anti-
Snail, anti-Vimentin (1:1000, Dizhao, Nanjing, China) and anti-
GAPDH (1:5000, kangcheng, China). All results were visualized
through a chemiluminescent detection system (Pierce ECL Sub-
strate Western blot detection system, Thermo, Pittsburgh, PA)
and then exposed in Molecular Imager ChemiDoc XRS System
(Bio-Rad, Hercules, CA).
2.8. Transient transfection
The cells were seeded into 6-well plates and transfected with
50 nM siRNA/SOX2 and siRNA/control (GenePharma, Shanghai,
China) using Lipofectamine 2000 (Invitrogen, USA) according to
the instructions provided by the manufacturer. Oligonucleotides
NC (miR-control), miR-638 mimics (hsa-miR-638 mimics), inhibi-
tor NC (anti-miR-control), hsa-miR-638 inhibitor (anti-miR-638)
were purchased from GenePharma (Shanghai, PR China). Transfec-
tion of cells with oligonucleotides was performed using Lipofect-
amine 2000 Reagent (Invitrogen, Carlsbad, CA, USA) at a ﬁnal
concentration of 100 nM. Transfection efﬁciency was monitored
by qRT-PCR.
2.9. Bioinformatics analysis
We used bioinformatics method to predict the potential target-
ing genes of miR-638. According to the results shown in the Target-
Scan (http://www.targetscan.org/) database, SOX2 was the
candidate gene. The result from bioinformatic software indicated
that 30-UTR of SOX2 binds to miR-638 with the high score.
2.10. Luciferase assay
Fourty eight hours after transfection, luciferase actions were
measured in Victor 1420 Multilabel Counter (Wallac, Finland)
using Luciferase Assay System (Promega, USA) according to the
manufacturer’s protocol.
2.11. Statistical methods
Statistical analysis was performed using STAT11 and GraphPad
Prism (version 5.01; GraphPad Software, Inc, La Jolla, CA) statistical
software. The chi-squared test was used to test the signiﬁcance of
observed differences in the Table 1 data and the t-test was used for
the other data analyses. The signiﬁcance was accepted as P value
was less than 0.05.
3. Results
3.1. miR-638 expression is down-regulated and inversely correlates
with SOX2 expression in human lung cancer tissues
The expression levels of miR-638 and SOX2 were detected in
NSCLC specimens (n = 107) and corresponding adjacent tissues
(n = 107) by using qRT-PCR. Signiﬁcantly lower miR-638
(P < 0.05; Fig. 1A) and higher SOX2 (P < 0.05; Fig. 1B) RNA levels
were detected in tumor specimens as compared with adjacent
areas. The median was used as cut off. Moreover, a negative corre-
lation was observed between miR-638 and SOX2 (R = 0.645;
P < 0.0001; Fig. 1C) in cancer samples. The relationship between
Table 1
Correlation between miR-638 (or SOX2) status and clinical characteristics in patients with NSCLC.
Characteristics All
Patients
miR-638 low expression
(6Median)
miR-638 high expression
(>Median)
P value SOX2 low expression
(<Median)
SOX2 high expression
(PMedian)
P value
No. 107 54 53 53 54
Age (years) 0.913 0.618
<60 47 24 23 22 25
P60 60 30 30 31 29
Gender 0.766 0.928
Male 50 26 24 25 25
Female 57 28 29 28 29
Histology 0.916 0.622
AC 49 25 24 23 26
SCC 58 29 29 30 28
Tumor size 0.015* 0.005**
T1/T2 46 17 29 30 16
T3/T4 61 37 24 23 38
Tumor stage 0.016* 0.001**
I–II 52 20 32 34 18
III–IV 55 34 21 19 36
Metastasis 0.003** 0.000**
Yes 37 26 11 9 28
No 70 28 42 44 26
AC: adenocarcinoma; SCC: suqamous cell carcinoma; NSCLC: non-small-cell lung cancer.
* Indicates P value < 0.05.
** Indicates P value < 0.01.
Fig. 1. miR-638 is reduced and SOX2 is elevated in NSCLC patients. (A) miR-638 mRNA expression in NSCLC patients (n = 107) and corresponding adjacent tissues (n = 107)
relative to U6 detected by using qRT-PCR (P < 0.05). T refers to tumor tissues and P refers to corresponding adjacent tissues. (B) The mRNA expression level of SOX2 relative to
GAPDH in human NSCLC tissues and corresponding adjacent tissues were also investigated by using qRT-PCR. T refers to tumor tissues and P refers to corresponding adjacent
tissues. (C) A negative correlation was found between RNA expression of miR-638 and SOX2 in tumor samples (R = 0.645; P < 0.0001). (D) Expression of miR-638 was
analyzed in ﬁve lung cancer cell lines (A549, H1299, SPCA1, H1650 and H358) and normal lung cell (BEAS2B). Data are represented as mean ± S.E.M. ⁄ Indicates P < 0.05.
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teristics were exhibited in Table 1. Age, gender and histology were
not associated with the expression of miR-638 or SOX2. However,tumor size (P < 0.05) and higher metastasis rate (P < 0.01) were
observed signiﬁcantly in both low-miR-638 and high-SOX2 expres-
sion groups, which supported the result of correlation analysis,
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these results indicated that miR-638 (SOX2) might be involved in
the metastasis of patients with NSCLC.
3.2. miR-638 regulated the invasive ability of NSCLC cell lines in vitro
To investigate the role of miR-638 expression in NSCLC, we
explored the effect of miR-638 on cell invasion by using a transwell
invasion assay. In this study, expression of miR-638 was detected
in ﬁve lung cancer cell lines (A549, H1299, SPCA1, H1650 and
H358) and a normal lung cell line (BEAS2B). Expression of miR-
638 in A549 and SPCA1 was between those in H1650 and in
H358 (H1299) (Fig. 1D). Based on this expression pattern, we chose
the A549 and SPCA1 lung cancer cell lines to verify the effect of
miR-638. Therefore, A549 and SPCA1 cell lines were transfected
with NC (mimics negative control), miR-638 mimics, inhibitor NC
and miR-638 inhibitor, respectively. The transfection efﬁciency
was validated by using qRT-PCR (Fig. 2A). The invasion assay
showed that overexpression of miR-638 inhibited cell lines inva-
sion, whereas downregulation of miR-638 expression promoted
the invasive ability of NSCLC cell lines (Fig. 2B). These data sug-
gested that miR-638 could inhibit the invasive ability of NSCLC cell
lines in vitro.
3.3. miR-638 inhibits cell proliferation but has no effect on cell
apoptosis
To further detect whether miR-638 could regulate NSCLC cell
lines proliferation in vitro, the effect of miR-638 on proliferation
was detected by using MTT assay. The assay showed that the cell
survival of cells transfected with miR-638 mimics in cell lines
was signiﬁcantly less than the controls. Meanwhile, the survival
of cells transfected with miR-638 inhibitor in cell lines was more
than the controls (Fig. 3A). Moreover, we also performed apoptosis
assay to investigate the effect of miR-638 on cell apoptosis. How-
ever, there was no obvious difference (Fig. 3B). These results indi-
cated that miR-638 could inhibit cell lines proliferation but have
no effect on cell apoptosis in vitro.Fig. 2. miR-638 regulates the invasive ability of NSCLC cell lines in vitro. (A) The resu
inhibitor, control for miR-mimics (NC) and control for miR-638 inhibitor (inhibitor NC) w
Section 2. A549 and SPCA1 were treated with miR-638 mimics, miR-638 inhibitor, NC an
the membrane stained with crystal violet were visualized as shown. The quantiﬁcations
performed in triplicate and presented as mean ± S.E.M. ⁄ Indicates signiﬁcant differen
performed three times.3.4. miR-638 could regulate SOX2 expression by directly binding its 30-
UTR
Based on bioinformatics analysis, microRNA.org (http://
www.microrna.org/microrna/), miRDB (http://mirdb.org/cgi-bin/),
and TargetScan (http://www.targetscan.org/) database, bioinfor-
matic software indicated that 30-UTR (untranslated region) of
SOX2 binds to miR-638 with the high score (mirSVR score:
1.2934). According to the results of prediction, the 30-UTR frag-
ment containing the predicted site was cloned into pGL3 luciferase
reporter vector (pGL3–SOX2) to further determine the relationship
between miR-638 and SOX2 expression. The 30-UTR fragment with
mutant sequence was also cloned as a control group (pGL3–SOX2–
MUT) in the predicted target site. The luciferase activity decreased
in A549 cells with miR-638 mimics and pGL3–SOX2 vectors. How-
ever, miR-638 mimics did not have any effect on luciferase activity
when target cells were transfected with pGL3–SOX2–MUT vector
(Fig. 4A). The results indicated that SOX2 gene was one of the
direct targets of miR-638.
Subsequently, we performedWestern blot assay to examine the
expression of SOX2 responses to the changes of miR-638 expres-
sion in vitro. The assay showed the negative regulatory effect of
miR-638 on SOX2 both in A549 and SPCA1 cell lines. Up-regulated
miR-638 could decrease SOX2 expression; meanwhile, down-regu-
lated miR-638 could increase SOX2 expression level (Fig. 4B).
These ﬁndings implied that miR-638 could regulate SOX2 expres-
sion by directly binding its 30-UTR in NSCLC cell lines.
3.5. Silencing of SOX2 by siRNA partially abolished the enhancement of
cells invasion and proliferation induced by down-regulated miR-638
In various cancers, SOX2 has been indentiﬁed to promote pro-
liferation and invasion [16,17]. Here, we explored whether the
functional effect of miR-638 on NSCLC cell lines was dependent
on SOX2. As shown above, SOX2 was upregulated in cells which
were transfected with miR-638 inhibitor. Thus, we silenced the
expression of SOX2 by RNA interference. Both A549 and SPCA1
cells were co-transfected with miR-638 inhibitor and siRNA/lts of miR-638 expression in cell lines transfected with miR-638 mimics, miR-638
ere validated by using qRT-PCR. (B) Transwell assay was performed according to the
d inhibitor NC for 24 h. The representative images of invasive cells at the bottom of
of cell invasion were presented as percentage of cell numbers. All experiments were
ce compared with control group (P < 0.05). Every independent experiment was
Fig. 3. miR-638 inhibits cell proliferation but has no effect on cell apoptosis in vitro. (A) Absorbance at 490 nm was presented with Mean ± S.E.M. A549 (upper) and SPCA1
(down) (B) Flow cytometry assay was performed to assess cell apoptosis. A549 (upper) and SPCA1 (down) ⁄ indicates signiﬁcant difference compared with control group
(P < 0.05).
2242 Y. Xia et al. / FEBS Letters 588 (2014) 2238–2245SOX2. The transfection cells of miR-638 inhibitor and the co-trans-
fection cells of miR-638 inhibitor and siRNA/control were regarded
as the control groups. The transfection efﬁciency was conﬁrmed
by using qRT-PCR and Western blot assays (Fig. 5A). Compared
with the control groups, the expression level of SOX2 was obvi-
ously decreased both in A549 and SPCA1 cells co-transfected with
miR-638 inhibitor and siRNA/SOX2. Then, the MTT assay and
transwell invasion assay showed that silencing of SOX2 by RNA
interference (siRNA) partially abolished the enhancement of cells
invasion and proliferation induced by down-regulated miR-638,
as shown in Fig. 5B .3.6. Down regulation of miR-638 induces epithelial-to-mesenchymal
transition (EMT)
Epithelial-to-mesenchymal transition (EMT) has been identiﬁed
as a key role in the invasion of various cancer cells by the transfor-
mation of polarized and adherent epithelial cells into motile and
invasive mesenchymal cells. Thus, to explore whether miR-638
was involved in the EMT program, we investigated the epithelial
marker (E-cadherin) and mesenchymal markers (Fibronectin,
Vimentin and Snail) by Western blot. Cell lines were transfected
with NC, miR-638 mimics, inhibitor NC and miR-638 inhibitor. In
Fig. 4. miR-638 regulates SOX2 expression by directly binding its 30-UTR. (A) The potential miR-638 seed region at the 30-UTR of SOX2 mRNA was computationally predicted
by using TargetScan. A549 cells were co-transfected with miR-638 mimics (or NC) with pGL3-SOX2 (or pGL3-SOX2-MUT) vector. Luciferase activity was normalized by the
ratio of ﬁreﬂy and Renilla luciferase signals. (B) SOX2 protein expression levels in A549 and SPCA1 cells transfected with NC, miR-638 mimics, inhibitor NC and miR-638
inhibitor were analyzed by using Western-blotting. GAPDH was used as a control. All experiments were performed in triplicate and the band intensity values were analyzed
by using Image J. Then, the signiﬁcance in change in protein expression was analyzed by using statistical t-tests. Data are represented as mean ± S.E.M. ⁄ Indicates P < 0.05.
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resulted in evaluated E-cadherin expression and decreased Fibro-
nectin, Vimentin and Snail expression. Meanwhile, suppressed
miR-638 expression resulted in decreased E-cadherin expression
and increased Fibronectin, Vimentin and Snail expression
(Fig. 5C). This ﬁnding indicated that miR-638 might contribute to
regulating EMT marker expression in NSCLC in vitro.
4. Discussion
Lung cancer is one of the common causes of cancer-related
death in the world. The treatment for early-stage patients who
are diagnosed by the tumor, node, and metastasis (TNM) classiﬁca-
tion continues to be surgical resection; however, a considerable
number of these patients will develop metastasis or relapse even
when the surgeries are successful. The exploration of the mecha-
nisms of metastatis is crucial for improving surgery and treatment
outcome.
microRNAs (miRNAs) have been identiﬁed to play critical regu-
latory roles in cancer proliferation [18], invasion [19], prognosis
[20] and other biology processes in a variety of research disciplines
[21,22]. miRNAs indirectly regulate the target genes by binding
their 30-UTR. For example, miR-545 suppress cell proliferation by
targeting Cyclin D1 and CDK4 in lung cancer cells [23]. miR-638
suppressed gastric cancer cell proliferation by targeting Sp2 with
inﬂuence on the expression of cyclin D1 [24]. Here, the expression
of miR-638 was clearly decreased in NSCLC tissues. Aberrant
expression of miR-638 was related to the invasion and prolifera-
tion of NSCLC cell lines (A549 and SPCA1) in vitro. We also found
miR-638 overexpression diminished but miR-638 knockdown
increased SOX2 expression level in NSCLC cell lines by directly
binding the 30-UTR of SOX2. Similarly, we tried to elucidate the
reverse regulation of miR-638 and SOX2 within limits of NSCLC,
but we are unsure whether miR-638 has other targets related to
NSCLC proliferation and invasion. Due to the limited sample size
and the individual difference in patients in our research, the low
r (correlation value) of 0.645 does not seem very strong. Inadditional, 15 samples with the lower miR-638 (cutoff: 0.1) and
lower SOX2 (cutoff: 1.0) shared the same clinical feather including
the higher differentiation grade and TNM grade (IIa–IIb) compared
with the other samples. This might be reasonable that miR-638
was decreased as well as the relative lower expression of SOX2.
However, the expression of SOX2 in these 15 samples was still
higher in tumor tissues comparing with the adjacent correspond-
ing tissues. These ﬁndings suggested that changes in the develop-
ment of NSCLC should not be attributed to alternations of one or a
small quantity of genes. As the limit on the number of NSCLC sam-
ples and cell types, more elaborate studies will be necessary for
further exploration of the link between miR-638 and SOX2 and
its potential role in tumorigenesis.
SOX2, a transcription factor, has been reported as an oncogene
and it can negatively modulate the promoter activity of correspon-
dent downstream target genes. Prior reports indicated that aber-
rant SOX2 expression is related to development, progression, and
prognosis of multiple tumors by regulation of various cell signaling
pathways. In esophageal squamous cell carcinoma, SOX2 could
promote tumor growth through the AKT/mammalian target of rap-
amycin complex 1 signaling pathway [25]. In addition, SOX2 could
promote cancer cell invasion by activating Slug in hepatocellular
cancer [26]. In lung cancer, SOX2 could regulate cancer cells apop-
tosis through MAP4K4-Survivin signaling pathway [27]. The
emerging role of SOX2 in cell proliferation and survival by eliciting
oncogenic EGFR and BCL2L1 signaling was identiﬁed as a prognosis
marker and a therapeutic target [28]. Wnt signaling substantially
could impact NSCLC tumorigenesis, prognosis, and resistance to
therapy [29]. Recently, Li et al. reported that SOX2 could promote
tumor metastasis by stimulating epithelial-to-mesenchymal tran-
sition via regulation of WNT/b-catenin signal network [30]. Here,
we found that SOX2 was overexpressed in NSCLC samples and
associated with tumor size and metastasis. This supports the view
that SOX2 is an oncogene, which is consistent with a recent study
[31]. Furthermore, we discovered that silencing of SOX2 by siRNA
partially abolished the enhancement of cells invasion and prolifer-
ation induced by down-regulated miR-638. This result was borne
Fig. 5. Expression of SOX2 abrogated the anti-invasion and anti-proliferation functions of miR-638. (A) Both A549 and SPCA1 cells were co-transfected with miR-638
inhibitor and siRNA/SOX2. The transfection cells of miR-638 inhibitor and the co-transfection cells of miR-638 inhibitor and siRNA/control were regarded as the control
groups. The transfection efﬁciency was conﬁrmed by using qRT-PCR and Western blot assays. (B) Transwell assay was performed according to the Section 2. The
representative images of invasive cells at the bottom of the membrane stained with crystal violet were visualized as shown. The quantiﬁcations of cell invasion were
presented as percentage of cell numbers. Absorbance at 490 nmwas presented with Mean ± S.E.M. (C) Fibronectin, Vimentin, E-cadherin and Snail protein expression levels in
A549 cells transfected with NC, miR-638 mimics, inhibitor NC, and miR-638 inhibitor were analyzed by using Western-blotting. GAPDH was used as a control. Average values
of integrated optical density (IOD) were assessed by analyzing ﬁve ﬁelds per slide and recorded in the histogram. ⁄ Indicates P < 0.05.
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dent on SOX2.
Epithelial-to-mesenchymal transition (EMT) is considerated to
be involved in migration, tumor invasion and dissemination [32].
Decreased E-cadherin and elevated Vimentin and Snail expression
is one hallmark of EMTwhich is a key element in the cancer invasion
[33].Manystudies established functional associationsbetweennon-
codingmicroRNAs and key effectors of EMT occurring in the context
of carcinogenesisandembryonicdevelopment, suchasmiR-200 [34]
and miR-10b [35]. In addition to cancer progression, EMT contrib-
utes to chronic epithelial injury [36], leading to tissue ﬁbrosis and
organ failure. In this study, up-regulated miR-638 expression
resulted in increased E-cadherin expression and decreased Fibro-
nectin, Vimentin and Snail expression. Meanwhile, suppressed
miR-638 expression resulted in decreased E-cadherin expression
and increased Fibronectin, Vimentin and Snail expression.
Taken together, lower miR-638 and higher SOX2 expression lev-
els were detected in NSCLC samples (n = 107) than in correspond-
ing adjacent tissues (n = 107) and both of them were related to
tumor size and metastasis. Aberrant expression of miR-638 could
regulate the proliferation and invasive ability of cell lines by
directly binding SOX2 30-UTR in vitro. Moreover, down-regulated
miR-638 also could induce epithelial-to-mesenchymal transition
(EMT). In future, therapeutic interventions focusing on miR-638-
SOX2 may help hinder the development/progression of human
lung cancer.
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